Newborn Cured of HIV

A little girl in Mississippi, who was born infected with HIV, was apparently cured of the disease after receiving a three drug cocktail shortly after birth. More 

Opko Health’s Insider Buying: A Rx for Profits?

Huge insider buying by Opko Health's CEO is a positive force, and the company itself has a diversified business, but an OPK investment still carries plenty of risk. More 

18 Metals and Mining Stocks to Sell Now

This week, the ratings of 18 Metals and Mining stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

Biotech Movers: Affymax Crashes on Recall

Last week, shares of Affymax got hammered when the company pulled back units of its sole commercial drug. Plus, find out what sent the biggest gainers skyward. More 

Reserve Your Spot in OpenTable

Breakouts tend to fail, but breakouts that close above resistance with authority and volume have a better chance of moving higher -- and such is the case with OpenTable. More 

Invest in the Purina Portfolio

Over a span of 32 years, former Ralston Purina CEO Bill Stiritz created tremendous value for shareholders. Here are 10 stocks that have benefited from his legacy -- and could have a place in your portfolio. More 

3 Medical Devices Stocks to Sell Now

This week, the overall grades of three Medical Devices stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More